Westlake Chemical Partners (NYSE:WLKP – Get Free Report) is scheduled to be issuing its quarterly earnings data before the market opens on Tuesday, November 5th. Analysts expect the company to announce earnings of $0.36 per share for the quarter. Parties that are interested in registering for the company’s conference call can do so using this link.
Westlake Chemical Partners (NYSE:WLKP – Get Free Report) last posted its quarterly earnings results on Tuesday, August 6th. The basic materials company reported $0.41 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.44 by ($0.03). The company had revenue of $284.17 million during the quarter, compared to analysts’ expectations of $270.28 million. Westlake Chemical Partners had a return on equity of 6.68% and a net margin of 4.78%. During the same period in the prior year, the firm earned $0.34 EPS. On average, analysts expect Westlake Chemical Partners to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Westlake Chemical Partners Stock Performance
Shares of WLKP stock opened at $22.35 on Friday. The company has a market capitalization of $787.39 million, a price-to-earnings ratio of 13.88 and a beta of 1.10. The company has a debt-to-equity ratio of 0.48, a quick ratio of 4.59 and a current ratio of 4.68. Westlake Chemical Partners has a one year low of $21.16 and a one year high of $23.68. The company’s 50-day moving average is $22.43 and its 200 day moving average is $22.52.
Westlake Chemical Partners Cuts Dividend
Insider Activity at Westlake Chemical Partners
In other Westlake Chemical Partners news, SVP Andrew Kenner bought 12,000 shares of the firm’s stock in a transaction on Friday, August 9th. The stock was acquired at an average price of $22.99 per share, with a total value of $275,880.00. Following the transaction, the senior vice president now owns 182,308 shares in the company, valued at $4,191,260.92. This represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Insiders have acquired 16,119 shares of company stock valued at $369,340 over the last ninety days. Insiders own 1.10% of the company’s stock.
Analysts Set New Price Targets
Separately, Barclays upgraded shares of Westlake Chemical Partners to a “strong-buy” rating in a report on Monday, August 12th.
Get Our Latest Research Report on WLKP
Westlake Chemical Partners Company Profile
Westlake Chemical Partners LP acquires, develops, and operates ethylene production facilities and related assets in the United States. The company’s ethylene production facilities primarily convert ethane into ethylene. It also sells ethylene co-products, such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen directly to third parties on either a spot or contract basis.
Recommended Stories
- Five stocks we like better than Westlake Chemical Partners
- Following Congress Stock Trades
- Battle of the Retailers: Who Comes Out on Top?
- The Basics of Support and Resistance
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- Learn Technical Analysis Skills to Master the Stock Market
- MarketBeat Week in Review – 10/28 – 11/1
Receive News & Ratings for Westlake Chemical Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Westlake Chemical Partners and related companies with MarketBeat.com's FREE daily email newsletter.